When to reassess If GI symptoms worsen instead of improving over the first 2-3 weeks of a step, if dysesthesia appears suddenly, or if you cannot keep food down, pause and consult a qualified clinician
His concern is structural: if compounding eligibility becomes a commercially viable alternative to the full drug approval pathway, pharmaceutical developers will have a financial incentive to bypass Phase III trials entirely
The combination is particularly relevant for anti-aging protocols, skin regeneration, and wound healing applications
It is one of the reasons bedtime dosing is not just preferred but specifically designed into this protocol
The question is whether it fits the patients condition, risk profile, treatment goals, and a supervised plan
Headache 54 , 11731183 (2014)